Inflammatory myofibroblastic liver tumor
Inflammatory myofibroblastic tumors (inflammatory myofibroblastic tumors) IMT in the clinical practice of an oncologist are very rare diagnostic findings. Currently, the bulk of scientific publications about IMT are devoted to reviews of clinical cases. If initially IMT were considered as pseudo-tum...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2022-03-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/768 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841524391367671808 |
|---|---|
| author | A. D. Kaprin S. A. Ivanov A. A. Nevolskikh L. O. Petrov A. G. Isaeva R. F. Zibirov A. A. Izmailov |
| author_facet | A. D. Kaprin S. A. Ivanov A. A. Nevolskikh L. O. Petrov A. G. Isaeva R. F. Zibirov A. A. Izmailov |
| author_sort | A. D. Kaprin |
| collection | DOAJ |
| description | Inflammatory myofibroblastic tumors (inflammatory myofibroblastic tumors) IMT in the clinical practice of an oncologist are very rare diagnostic findings. Currently, the bulk of scientific publications about IMT are devoted to reviews of clinical cases. If initially IMT were considered as pseudo-tumors, now they are classified as intermediate fibroblastic/myofibroblastic tumors according to the WHO histological classification. Management of patients with hepatic IMT are debatable today. Hepatic IMT are mostly benign lesions and characterized by spontaneous regression without any treatment. However, sometimes therapeutic and surgical treatment of these lesions is necessary. Many authors recommend surgical treatment, as with conservative treatment, some patients develop relapses. This rare observation demonstrates our experience of liver resection for inflammatory myofibroblastic liver tumor in 76 year-old patient. |
| format | Article |
| id | doaj-art-e5ee8acca3da4eed91542dc360df86fe |
| institution | Kabale University |
| issn | 2410-1893 |
| language | Russian |
| publishDate | 2022-03-01 |
| publisher | QUASAR, LLC |
| record_format | Article |
| series | Исследования и практика в медицине |
| spelling | doaj-art-e5ee8acca3da4eed91542dc360df86fe2025-02-03T07:12:12ZrusQUASAR, LLCИсследования и практика в медицине2410-18932022-03-019112513110.17709/2410-1893-2022-9-1-11436Inflammatory myofibroblastic liver tumorA. D. Kaprin0S. A. Ivanov1A. A. Nevolskikh2L. O. Petrov3A. G. Isaeva4R. F. Zibirov5A. A. Izmailov6National Medical Research Radiological Centre; P. A. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre; Peoples' Friendship University of RussiaA. F. Tsyb Medical Radiological Research Center – Branch of the National Medical Research Radiological CenterA. F. Tsyb Medical Radiological Research Center – Branch of the National Medical Research Radiological CenterA. F. Tsyb Medical Radiological Research Center – Branch of the National Medical Research Radiological CenterA. F. Tsyb Medical Radiological Research Center – Branch of the National Medical Research Radiological CenterA. F. Tsyb Medical Radiological Research Center – Branch of the National Medical Research Radiological CenterP. A. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological CentreInflammatory myofibroblastic tumors (inflammatory myofibroblastic tumors) IMT in the clinical practice of an oncologist are very rare diagnostic findings. Currently, the bulk of scientific publications about IMT are devoted to reviews of clinical cases. If initially IMT were considered as pseudo-tumors, now they are classified as intermediate fibroblastic/myofibroblastic tumors according to the WHO histological classification. Management of patients with hepatic IMT are debatable today. Hepatic IMT are mostly benign lesions and characterized by spontaneous regression without any treatment. However, sometimes therapeutic and surgical treatment of these lesions is necessary. Many authors recommend surgical treatment, as with conservative treatment, some patients develop relapses. This rare observation demonstrates our experience of liver resection for inflammatory myofibroblastic liver tumor in 76 year-old patient.https://www.rpmj.ru/rpmj/article/view/768liver tumorsliver surgeryinflammatory tumorshepatobiliary surgery |
| spellingShingle | A. D. Kaprin S. A. Ivanov A. A. Nevolskikh L. O. Petrov A. G. Isaeva R. F. Zibirov A. A. Izmailov Inflammatory myofibroblastic liver tumor Исследования и практика в медицине liver tumors liver surgery inflammatory tumors hepatobiliary surgery |
| title | Inflammatory myofibroblastic liver tumor |
| title_full | Inflammatory myofibroblastic liver tumor |
| title_fullStr | Inflammatory myofibroblastic liver tumor |
| title_full_unstemmed | Inflammatory myofibroblastic liver tumor |
| title_short | Inflammatory myofibroblastic liver tumor |
| title_sort | inflammatory myofibroblastic liver tumor |
| topic | liver tumors liver surgery inflammatory tumors hepatobiliary surgery |
| url | https://www.rpmj.ru/rpmj/article/view/768 |
| work_keys_str_mv | AT adkaprin inflammatorymyofibroblasticlivertumor AT saivanov inflammatorymyofibroblasticlivertumor AT aanevolskikh inflammatorymyofibroblasticlivertumor AT lopetrov inflammatorymyofibroblasticlivertumor AT agisaeva inflammatorymyofibroblasticlivertumor AT rfzibirov inflammatorymyofibroblasticlivertumor AT aaizmailov inflammatorymyofibroblasticlivertumor |